|
Carrie S. Cox is executive vice president and president, Global Pharmaceuticals, for Schering-Plough Corporation.
Cox joined Schering-Plough in May 2003. Her appointment consolidated Schering-Plough’s prescription pharmaceutical business from several autonomous units into a unified Global Pharmaceutical Business that today includes global sales, marketing, advertising, product public relations, business operations, medical affairs and commercial development. Cox is responsible for leading the transformation of the Global Pharmaceutical Business into a profitable, high-performing organization.
Prior to joining Schering-Plough, Cox was the executive vice president and president of the Global Prescription Business at Pharmacia Corporation, prior to its merger with Pfizer.
A registered pharmacist, Cox has more than 20 years of experience in the pharmaceutical industry. She joined Pharmacia’s predecessor company, Pharmacia & Upjohn, in 1997 as senior vice president and head of Global Business Management, and was a principal architect of that company’s dramatic turnaround. She was appointed executive vice president in 1999.
Previously, Cox served as vice president of Women’s Health Care at Wyeth, where she worked for seven years. Prior to that assignment, she held a variety of positions in market research, sales and product management during a 10-year career with Sandoz Pharmaceuticals (now Novartis).
Cox is a member of the Harvard School of Public Health’s Health Policy and Management Executive Council. She also serves as a member of the Board of Directors of Texas Instruments and as a member of that board’s audit committee. Cox is also a member of the Board of Overseers of the University of Pennsylvania Museum of Archaeology and Anthropology.
Fortune magazine twice named Cox to its list of the 50 Most Powerful Women in Business, and the Healthcare Businesswomen’s Association named her Healthcare Businesswoman of the Year.
Cox is a graduate of the Massachusetts College of Pharmacy.
Schering-Plough Corporation is a global science-based health care company with leading prescription, consumer and animal health products. Through internal research and collaborations with partners, Schering-Plough discovers, develops, manufactures and markets advanced drug therapies to meet important medical needs. Schering-Plough’s vision is to earn the trust of the physicians, patients and customers served by its more than 32,000 people around the world. This company’s headquarters is based in Kenilworth, N.J., and its Web site is www.schering-plough.com. | 